MarketPeel
Insider Trading Intelligence
Pricing
…
DL

Deerfield Mgmt Hif, L.p.

NUVL
DIRECTOR · NUVALENT, INC. · CIK 0001665736
FILING MIX · LIFETIME65%/35%
BUYS
31
SELLS
17
TOTAL VALUE
$297.51M
COMPANIES
4
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
19,604,386
AVG SELL PX
$86.82
TRADE KIND
SHOWING 48 / 48
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
27 backtested trades · 8 horizons · 21 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Deerfield Mgmt Hif, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d27+74.07%-3.04%-1.81%-1.23%-2.39%—
14d27+70.37%-2.90%-1.69%-1.21%-5.90%—
30d27+77.78%-5.73%-1.18%-4.55%-3.93%—
60d27+25.93%+4.26%+3.03%+1.23%-4.11%—
90d27+37.04%+0.38%+1.77%+4.70%+7.38%—
180d27(4 pending)+78.26%-7.21%+5.83%-13.02%-14.46%—
1y27(8 pending)+15.79%-4.19%+2.92%-7.11%+8.87%—
2y27(9 pending)+16.67%+20.12%+24.10%-3.98%-25.68%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NUVL · 8,299,225 shares · as of Nov 24, 2025
03,252,9976,505,9949,758,99113,011,9882022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 31 buys / 17 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
1,084,010$5.00$5.42M10,622,928Feb 27, 2026Mar 2, 2026 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
2,000,000$5.00$10.00M6,207,982Feb 27, 2026Mar 2, 2026 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
1,084,012$5.00$5.42M10,622,957Feb 27, 2026Mar 2, 2026 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
831,978$5.00$4.16M8,153,107Feb 27, 2026Mar 2, 2026 ↗View →
NUVL
NUVALENT, INC.
SALE
371,287$95.45$35.44M8,299,225Nov 24, 2025Nov 24, 2025 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
2,599,932$3.20$8.32M7,321,129Jul 31, 2025Aug 4, 2025 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
3,387,529$3.20$10.84M9,538,918Jul 31, 2025Aug 4, 2025 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
3,387,539$3.20$10.84M9,538,945Jul 31, 2025Aug 4, 2025 ↗View →
PHGE
BIOMX INC.
PURCHASEGRANT
Stock grant
1,611,864——1,611,864Apr 21, 2025Apr 23, 2025 ↗View →
PHGE
BIOMX INC.
PURCHASEGRANT
Stock grant
1,258,614——1,258,614Feb 27, 2025Mar 3, 2025 ↗View →
PHGE
BIOMX INC.
SALE
1,611,863——405,637Feb 27, 2025Mar 3, 2025 ↗View →
PHGE
BIOMX INC.
PURCHASE
353,249$0.93$328.7K1,247,054Feb 27, 2025Mar 3, 2025 ↗View →
NUVL
NUVALENT, INC.
SALE
1,000,000$97.75$97.75M8,670,512Oct 22, 2024Oct 24, 2024 ↗View →
PHGE
BIOMX INC.
SALE
5,883——47,957Jul 15, 2024Jul 17, 2024 ↗View →
PHGE
BIOMX INC.
PURCHASE
5,883,000——8,938,049Jul 15, 2024Jul 17, 2024 ↗View →
PHGE
BIOMX INC.
PURCHASEGRANT
Stock grant
722,175——722,175Jul 9, 2024Jul 11, 2024 ↗View →
PHGE
BIOMX INC.
PURCHASEGRANT
Stock grant
20,175,000——20,175,000Jul 9, 2024Jul 11, 2024 ↗View →
PHGE
BIOMX INC.
PURCHASEGRANT
Stock grant
3,055,049——3,055,049Mar 15, 2024Mar 19, 2024 ↗View →
PHGE
BIOMX INC.
PURCHASEGRANT
Stock grant
13,490——13,490Mar 15, 2024Mar 19, 2024 ↗View →
PHGE
BIOMX INC.
PURCHASEGRANT
Stock grant
40,350——53,840Mar 15, 2024Mar 19, 2024 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
1,430,205$8.74$12.50M4,207,982Feb 16, 2024Feb 16, 2024 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
1,430,206$8.74$12.50M6,151,406Feb 16, 2024Feb 16, 2024 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
1,430,206$8.74$12.50M6,151,389Feb 16, 2024Feb 16, 2024 ↗View →
NUVL
NUVALENT, INC.
PURCHASE
650,000$33.50$21.77M650,000Nov 3, 2022Nov 7, 2022 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
2,777,777$3.15$8.75M4,721,183Sep 16, 2022Sep 20, 2022 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
2,777,777$3.15$8.75M4,721,200Sep 16, 2022Sep 20, 2022 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
2,777,777$3.15$8.75M2,777,777Sep 16, 2022Sep 20, 2022 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
2,777,777$3.15$8.75M4,721,197Sep 16, 2022Sep 20, 2022 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
6,909$24.47$169.1K1,704,244Jun 6, 2022Jun 8, 2022 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
13,132$25.29$332.1K1,711,324Jun 6, 2022Jun 8, 2022 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
11,868$25.29$300.1K1,546,588Jun 6, 2022Jun 8, 2022 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
171$25.08$4.3K1,711,153Jun 6, 2022Jun 8, 2022 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
155$25.08$3.9K1,546,433Jun 6, 2022Jun 8, 2022 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
6,243$24.47$152.8K1,540,190Jun 6, 2022Jun 8, 2022 ↗View →
NUVL
NUVALENT, INC.
PURCHASE
897,671——9,670,511Aug 2, 2021Aug 4, 2021 ↗View →
NUVL
NUVALENT, INC.
PURCHASE
8,494,140——8,772,840Aug 2, 2021Aug 4, 2021 ↗View →
NUVL
NUVALENT, INC.
PURCHASE
300,000$17.00$5.10M2,717,628Aug 2, 2021Aug 4, 2021 ↗View →
NUVL
NUVALENT, INC.
SALE
4,831,384——0Aug 2, 2021Aug 4, 2021 ↗View →
NUVL
NUVALENT, INC.
SALE
13,011,988——0Aug 2, 2021Aug 4, 2021 ↗View →
NUVL
NUVALENT, INC.
SALE
45,716,568——13,011,988Aug 2, 2021Aug 4, 2021 ↗View →
NUVL
NUVALENT, INC.
PURCHASE
2,417,628——2,417,628Aug 2, 2021Aug 4, 2021 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
99,325$15.81$1.57M0Jul 9, 2021Jul 13, 2021 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
6,837$15.87$108.5K99,325Jul 7, 2021Jul 7, 2021 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
49,239$16.20$797.4K106,162Jul 6, 2021Jul 7, 2021 ↗View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
10,599$17.01$180.3K155,401Jul 2, 2021Jul 7, 2021 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
228,571$8.75$2.00M1,943,423Jun 30, 2021Jul 2, 2021 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
228,570$8.75$2.00M1,943,420Jun 30, 2021Jul 2, 2021 ↗View →
LRMR
LARIMAR THERAPEUTICS, INC.
PURCHASE
228,569$8.75$2.00M1,943,406Jun 30, 2021Jul 2, 2021 ↗View →
Other insiders · NUVL
Loading peer insiders…
About this filer
CIK 0001665736
ROLE
Director
PRIMARY
NUVL
COMPANIES
4
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001665736DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback